Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Saha, K. & Jaenisch, R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5, 584–595 (2009). Takahashi, K. & Yamanaka, S. Induction of ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Most of the human induced pluripotent stem cells stored at major cell line repositories and used in research harbor thousands of DNA errors, a study finds, highlighting the need for improved quality ...

Dr. Christopher Navara has 15 years of experience in pluripotent stem cell research including both humans and non-human primates ... They also have spontaneous and induced action potentials and they ...

For decades, scientists assumed that neural stem cells (NSCs) only occur in the brain and spinal cord. A new international ...

Human induced Pluripotent Stem Cells (hiPSCs), these are cells extracted from a patient's skin or blood and are reprogrammed by researches to replicate as stem cells. Researchers can now examine ...

The papers, published in Nature, investigate the use of cells derived from human induced pluripotent stem cells and human embryonic stem cells, respectively. Parkinson’s disease is a ...

We provide locally derived human pluripotent stem cell lines and generate induced pluripotent stem cell (iPSC) lines from somatic cells provided by the client. BSCC operates on a fee-for-service basis ...

Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.

A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.